The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...

Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

For years, Alzheimer’s disease has been considered a brain disorder that leads to memory loss and cognitive decline. It’s a ...

Mar. 12, 2025 — Lupus is an autoimmune disease where the body's immune system attacks its own tissues and organs, causing inflammation and damaging organs. A new study has now shown that the ...

Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...

Uniklinikum Erlangen at Friedrich-Alexander-Universität Erlangen-Nürnberg has successfully treated more than 45 people with autoimmune diseases using a novel innovative therapy using CAR-T cells since ...

Previously, no family has been reported in which acute systemic lupus erythematosus ... of which showed only benign hyperplasia. Abnormal cells were found in the blood, and a diagnosis of leukemic ...

Please provide your email address to receive an email when new articles are posted on . Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related ...

Tolerability was assessed by monitoring for Cytokine-release syndrome (CRS) and Immune-related effector Cell Neurotoxicity Syndrome (ICANS). Preliminary efficacy was assessed by reaching a Lupus Low ...